rs2305081
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001845.6(COL4A1):c.2716+99C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.148 in 1,267,340 control chromosomes in the GnomAD database, including 14,823 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.13 ( 1551 hom., cov: 32)
Exomes 𝑓: 0.15 ( 13272 hom. )
Consequence
COL4A1
NM_001845.6 intron
NM_001845.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.23
Publications
4 publications found
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
- brain small vessel disease 1 with or without ocular anomaliesInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
- autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
- microangiopathy and leukoencephalopathy, pontine, autosomal dominantInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- familial porencephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pontine autosomal dominant microangiopathy with leukoencephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinal arterial tortuosityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 13-110177743-G-A is Benign according to our data. Variant chr13-110177743-G-A is described in ClinVar as [Benign]. Clinvar id is 1225740.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.16 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL4A1 | NM_001845.6 | c.2716+99C>T | intron_variant | Intron 33 of 51 | ENST00000375820.10 | NP_001836.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.131 AC: 19871AN: 151768Hom.: 1547 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
19871
AN:
151768
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.151 AC: 168034AN: 1115454Hom.: 13272 AF XY: 0.150 AC XY: 85809AN XY: 570436 show subpopulations
GnomAD4 exome
AF:
AC:
168034
AN:
1115454
Hom.:
AF XY:
AC XY:
85809
AN XY:
570436
show subpopulations
African (AFR)
AF:
AC:
1300
AN:
26936
American (AMR)
AF:
AC:
8094
AN:
42418
Ashkenazi Jewish (ASJ)
AF:
AC:
4522
AN:
23760
East Asian (EAS)
AF:
AC:
3224
AN:
37626
South Asian (SAS)
AF:
AC:
11021
AN:
78314
European-Finnish (FIN)
AF:
AC:
6725
AN:
48466
Middle Eastern (MID)
AF:
AC:
564
AN:
3546
European-Non Finnish (NFE)
AF:
AC:
125363
AN:
805300
Other (OTH)
AF:
AC:
7221
AN:
49088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
7599
15199
22798
30398
37997
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3772
7544
11316
15088
18860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.131 AC: 19881AN: 151886Hom.: 1551 Cov.: 32 AF XY: 0.131 AC XY: 9742AN XY: 74216 show subpopulations
GnomAD4 genome
AF:
AC:
19881
AN:
151886
Hom.:
Cov.:
32
AF XY:
AC XY:
9742
AN XY:
74216
show subpopulations
African (AFR)
AF:
AC:
2205
AN:
41458
American (AMR)
AF:
AC:
2528
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
AC:
696
AN:
3466
East Asian (EAS)
AF:
AC:
642
AN:
5118
South Asian (SAS)
AF:
AC:
700
AN:
4806
European-Finnish (FIN)
AF:
AC:
1365
AN:
10506
Middle Eastern (MID)
AF:
AC:
42
AN:
294
European-Non Finnish (NFE)
AF:
AC:
11078
AN:
67954
Other (OTH)
AF:
AC:
284
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
856
1712
2569
3425
4281
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
220
440
660
880
1100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
386
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.